Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
3,555.00
-145.00 (-3.92%)
Sep 11, 2024, 2:59 PM KST
Genome & Company Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 106,998 | 176,209 | 245,897 | 468,827 | 1,048,465 | 323,319 |
Market Cap Growth | -48.25% | -28.34% | -47.55% | -55.28% | 224.28% | - |
Enterprise Value | 104,390 | 151,242 | 185,907 | 383,841 | 1,026,945 | - |
Last Close Price | 3500.00 | 6245.00 | 8725.00 | 17350.00 | 39750.00 | 19650.00 |
PE Ratio | - | -3.72 | -4.74 | -13.67 | -24.91 | -3.72 |
PS Ratio | 4.20 | 12.33 | 17.46 | 1038.96 | 6962.78 | 7054.22 |
PB Ratio | 0.91 | 1.55 | 1.63 | 4.13 | 9.11 | -8.51 |
P/FCF Ratio | -3.47 | -3.45 | -4.88 | -16.15 | -53.33 | -30.12 |
P/OCF Ratio | -6.68 | -5.47 | -5.65 | -17.92 | -57.74 | -32.18 |
EV/Sales Ratio | 4.36 | 10.58 | 13.20 | 850.63 | 6819.87 | - |
EV/EBITDA Ratio | -3.73 | -3.23 | -3.87 | -11.46 | -40.81 | - |
EV/EBIT Ratio | -3.02 | -2.75 | -3.23 | -10.64 | -38.57 | - |
EV/FCF Ratio | -2.87 | -2.96 | -3.69 | -13.22 | -52.23 | - |
Debt / Equity Ratio | 0.25 | 0.23 | 0.04 | 0.06 | 0.02 | -0.19 |
Debt / FCF Ratio | -0.76 | -0.52 | -0.12 | -0.24 | -0.09 | -0.69 |
Asset Turnover | 0.14 | 0.09 | 0.09 | 0.00 | 0.00 | - |
Inventory Turnover | 2.90 | 3.52 | 4.76 | - | - | - |
Quick Ratio | 3.48 | 3.16 | 9.83 | 8.03 | 36.89 | 0.47 |
Current Ratio | 3.75 | 3.44 | 10.49 | 8.32 | 37.00 | 0.48 |
Return on Equity (ROE) | -32.39% | -38.36% | -43.15% | -31.52% | -80.89% | - |
Return on Assets (ROA) | -15.59% | -20.55% | -23.17% | -17.48% | -21.33% | - |
Return on Capital (ROIC) | -18.08% | -23.20% | -25.95% | -19.03% | -38.58% | - |
Earnings Yield | -37.69% | -26.94% | -21.08% | -7.28% | -2.93% | -26.19% |
FCF Yield | -34.01% | -28.99% | -20.50% | -6.19% | -1.88% | -3.32% |
Buyback Yield / Dilution | -35.97% | -0.32% | -4.71% | -39.60% | -20.11% | - |
Total Shareholder Return | -35.97% | -0.32% | -4.71% | -39.60% | -20.11% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.